Short- and Long-Term Humoral and Cellular Immune Responses to SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis Treated with Disease-Modifying Therapies.
- Resource Type
- Article
- Source
- Vaccines; Apr2023, Vol. 11 Issue 4, p786, 12p
- Subject
HUMORAL immunity MULTIPLE sclerosis COVID-19 vaccines SARS-CoV-2 CELLULAR immunity VACCINATION - Language
- ISSN
- 2076393X